Indivior Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDV3d

   Indivior approves share issuance proposal

   • 91,206,182 shares voted at meeting
   • 85,455,705 votes for share issuance
   • 5,563,744 votes against
2. ROUTINE425Indivior Pharmaceuticals, Inc.INDVOct 6

   Indivior files Form 425 on Oct 6, 2026

   • Form 425 filed on Oct 6, 2026
   • Merger with Supernus pending
   • Supplemental disclosures added
3. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVOct 6

   Indivior announces merger with Supernus

   • Merger to be completed on October 15, 2026
   • Supernus to become subsidiary of Indivior
   • Indivior to be renamed Supernus, Inc.
4. ROUTINESCHEDULE 13GIndivior Pharmaceuticals, Inc.INDVSep 30

   Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

   MILLENNIUM MANAGEMENT LLC, filed by

5. ROUTINE425Indivior Pharmaceuticals, Inc.INDVSep 17

   Merger communication

6. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVSep 17

   Current report

7. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVSep 15

   Current report

8. ROUTINEEFFECTIndivior Pharmaceuticals, Inc.INDVSep 14

   Registration declared effective

9. ROUTINE424B3Indivior Pharmaceuticals, Inc.INDVSep 11

   Securities offering

10. ROUTINES-4/AIndivior Pharmaceuticals, Inc.INDVSep 9

    Merger registration (amended)

11. NOTABLES-4Indivior Pharmaceuticals, Inc.INDVAug 28

    Merger registration

12. ROUTINE4Indivior Pharmaceuticals, Inc.INDVAug 27

    Woodrow D Anderson, insider filing for INDV

    Woodrow D Anderson, reporting

13. NOTABLESCHEDULE 13D/AIndivior Pharmaceuticals, Inc.INDVAug 13

    Ownership stake disclosure by Oaktree Capital Holdings, LLC (amended)

    Oaktree Capital Holdings, LLC, filed by

14. ROUTINE4Indivior Pharmaceuticals, Inc.INDVAug 5

    Woodrow D Anderson, insider filing for INDV

    Woodrow D Anderson, reporting

15. ROUTINE425SUPERNUS PHARMACEUTICALS, INC.SUPNAug 3

    Merger communication

    Indivior Pharmaceuticals, Inc., filed by

16. NOTABLE10-QIndivior Pharmaceuticals, Inc.INDVAug 3

    Quarterly report

17. ROUTINE425Indivior Pharmaceuticals, Inc.INDVAug 3

    Merger communication

18. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVAug 3

    Current report

19. ROUTINE425Indivior Pharmaceuticals, Inc.INDVAug 3

    Merger communication

20. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVAug 3

    Current report

21. ROUTINE425Indivior Pharmaceuticals, Inc.INDVAug 3

    Merger communication

22. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVAug 3

    Current report

23. ROUTINE4Indivior Pharmaceuticals, Inc.INDVJul 13

    Christian Heidbreder, insider filing for INDV

    Christian Heidbreder, reporting

24. ROUTINE144Indivior Pharmaceuticals, Inc.INDVJul 10

    Christian Heidbreder, planned sale of INDV shares

    Christian Heidbreder, reporting

25. ROUTINE4Indivior Pharmaceuticals, Inc.INDVJun 23

    Joseph Ciaffoni, insider filing for INDV

    Joseph Ciaffoni, reporting

26. ROUTINE4Indivior Pharmaceuticals, Inc.INDVJun 12

    Christian Heidbreder, insider filing for INDV

    Christian Heidbreder, reporting

27. ROUTINE144Indivior Pharmaceuticals, Inc.INDVJun 11

    Christian Heidbreder, planned sale of INDV shares

    Christian Heidbreder, reporting

28. ROUTINE4Indivior Pharmaceuticals, Inc.INDVJun 10

    Ryan Preblick, insider filing for INDV

    Ryan Preblick, reporting

29. ROUTINE144/AIndivior Pharmaceuticals, Inc.INDVJun 8

    Ryan Preblick, planned sale of INDV shares (amended)

    Ryan Preblick, reporting

30. ROUTINE144Indivior Pharmaceuticals, Inc.INDVJun 8

    Ryan Preblick, planned sale of INDV shares

    Ryan Preblick, reporting

31. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVMay 15

    Current report

32. ROUTINESCHEDULE 13G/AIndivior Pharmaceuticals, Inc.INDVMay 15

    Ownership stake disclosure by Madison Avenue Partners, LP (amended)

    Madison Avenue Partners, LP, filed by

33. ROUTINE4Indivior Pharmaceuticals, Inc.INDVMay 14

    7 insider filings

    Keith Humphreys, insider filing for INDV

    Show all 7

    • 4Insider filing for INDVMay 14
    • 4Insider filing for INDVMay 14
    • 4Insider filing for INDVMay 14
    • 4Insider filing for INDVMay 14
    • 4Insider filing for INDVMay 14
    • 4Insider filing for INDVMay 14
    • 4Insider filing for INDVMay 14

    Keith Humphreys, reporting

34. ROUTINESCHEDULE 13G/AIndivior Pharmaceuticals, Inc.INDVMay 13

    Ownership stake disclosure by FULLER & THALER ASSET MANAGEMENT, INC. (amended)

    FULLER & THALER ASSET MANAGEMENT, INC., filed by

35. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVMay 4

    Current report

36. NOTABLE10-QIndivior Pharmaceuticals, Inc.INDVApr 30

    Quarterly report

37. ROUTINE8-KIndivior Pharmaceuticals, Inc.INDVApr 30

    Current report

38. ROUTINESCHEDULE 13GIndivior Pharmaceuticals, Inc.INDVApr 28

    Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC

    VANGUARD PORTFOLIO MANAGEMENT LLC, filed by

39. ROUTINESCHEDULE 13GIndivior Pharmaceuticals, Inc.INDVApr 27

    Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

    VANGUARD CAPITAL MANAGEMENT LLC, filed by

40. ROUTINEARSIndivior Pharmaceuticals, Inc.INDVMar 27

    Annual report to shareholders

41. ROUTINEDEFA14AIndivior Pharmaceuticals, Inc.INDVMar 27

    Additional proxy materials

42. ROUTINEDEF 14AIndivior Pharmaceuticals, Inc.INDVMar 27

    Proxy statement

43. ROUTINESCHEDULE 13GIndivior Pharmaceuticals, Inc.INDVMar 23

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

    MILLENNIUM MANAGEMENT LLC, filed by

44. ROUTINE4Indivior Pharmaceuticals, Inc.INDVMar 17

    Ryan Preblick, insider filing for INDV

    Ryan Preblick, reporting

Older filings on EDGAR